Release Date: 06/01/09 17:31 Summary: Audited annual fin. statements of Matsuoka 31 Dec 2007 Price Sensitive: No Download Document 708.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%